NCT04371575View on ClinicalTrials.gov

Symptomatic Trigeminal Neuralgia Attributed to Multiple Sclerosis - a Prospective Study in 60 Patients

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

September 1, 2012

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Trigeminal NeuralgiaMultiple SclerosisPain, Neuropathic
Interventions
DRUG

Carbamazepine

There is no actual intervention as the study is observational. First choice tratment is Carbamzepine and Oxcarbazepine. In medically refractory patients, first choice surgery is microvascular decompression

All Listed Sponsors
lead

Stine Maarbjerg, MD PhD

OTHER

NCT04371575 - Symptomatic Trigeminal Neuralgia Attributed to Multiple Sclerosis - a Prospective Study in 60 Patients | Biotech Hunter | Biotech Hunter